Addressing Mental Health Impacts of Skin Disease in Adolescents and Young Adults
DermConsultAddressing Mental Health Impacts of Skin Disease in Adolescents and Young Adults
Acne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
DermConsultAcne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
Dupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
DermConsultDupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
On the Frontlines of PsoriasisSkin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
What's New in Dermatology: Key Updates on Emerging Therapies
DermConsultWhat's New in Dermatology: Key Updates on Emerging Therapies
- advertisement
Taking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
CME/CETaking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
Raising the Bar on Obesity Management in Psoriasis and Psoriatic Arthritis: A Collaborative Learning Experience for Dermatology and Rheumatology Healthcare Professionals
CME/CERaising the Bar on Obesity Management in Psoriasis and Psoriatic Arthritis: A Collaborative Learning Experience for Dermatology and Rheumatology Healthcare Professionals
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CENo Patient Left Behind! Advancing CKD-Associated Pruritus Care
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
CME/CEFinally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
- advertisement
Tailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis
Medical Industry FeatureTailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis
Assessing Cutaneous Squamous Cell Carcinoma in People of Color
Medical Industry FeatureAssessing Cutaneous Squamous Cell Carcinoma in People of Color
Navigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care
Clinician's RoundtableNavigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care
- 07/08/2025
- 07/07/2025
- 07/07/2025
- 07/04/2025
- 07/04/2025
- 07/03/2025